Back to trial detailsIntake questionnaire
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Applying to Laura & Isaac Perlmutter Cancer Center at NYU Langone · New York, New York
Answer a few short questions to share with the research team.
0 of 3 answered